Novel Biologicals for the Treatment of Allergic Diseases and Asthma
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Novel Biologicals for the Treatment of Allergic Diseases and Asthma
Authors
Keywords
Allergy, Asthma, Biological, Biomarker, Endotype, Monoclonal antibodies
Journal
CURRENT ALLERGY AND ASTHMA REPORTS
Volume 16, Issue 10, Pages -
Publisher
Springer Nature
Online
2016-09-09
DOI
10.1007/s11882-016-0650-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Antisense molecules: A new class of drugs
- (2016) Daniel P. Potaczek et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Precision medicine in patients with allergic diseases: Airway diseases and atopic dermatitis—PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology
- (2016) Antonella Muraro et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Biomarkers in asthmatic patients: Has their time come to direct treatment?
- (2016) Alalia Berry et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Molecular and cellular mechanisms of food allergy and food tolerance
- (2016) R. Sharon Chinthrajah et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Advances and highlights in mechanisms of allergic disease in 2015
- (2016) Paulina Wawrzyniak et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Interleukins (from IL-1 to IL-38), interferons, transforming growth factor β, and TNF-α: Receptors, functions, and roles in diseases
- (2016) Mübeccel Akdis et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Type 2 innate lymphoid cells in induced sputum from children with severe asthma
- (2016) Prasad Nagakumar et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Toward precision medicine and health: Opportunities and challenges in allergic diseases
- (2016) Stephen Joseph Galli JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- A randomized, double-blind, placebo-controlled study of omalizumab combined with oral immunotherapy for the treatment of cow's milk allergy
- (2016) Robert A. Wood et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Endotypes of allergic diseases and asthma: An important step in building blocks for the future of precision medicine
- (2016) Ioana Agache et al. ALLERGOLOGY INTERNATIONAL
- Allergen immunotherapy for allergic asthma: protocol for a systematic review
- (2016) Sangeeta Dhami et al. Clinical and Translational Allergy
- EAACI IG Biologicals task force paper on the use of biologic agents in allergic disorders
- (2015) O. Boyman et al. ALLERGY
- The first trial of CIM331, a humanized antihuman interleukin-31 receptor A antibody, in healthy volunteers and patients with atopic dermatitis to evaluate safety, tolerability and pharmacokinetics of a single dose in a randomized, double-blind, placebo-co
- (2015) O. Nemoto et al. BRITISH JOURNAL OF DERMATOLOGY
- The Complex Type 2 Endotype in Allergy and Asthma: From Laboratory to Bedside
- (2015) Ioana Agache et al. CURRENT ALLERGY AND ASTHMA REPORTS
- Group 2 innate lymphocytes (ILC2) are enriched in active eosinophilic esophagitis
- (2015) Taylor A. Doherty et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- The future of biologics: Applications for food allergy
- (2015) Rebecca N. Bauer et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- T-cell regulation during viral and nonviral asthma exacerbations
- (2015) Agnieszka S. Wegrzyn et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- IL-13 mediates IL-33–dependent mast cell and type 2 innate lymphoid cell effects on bronchial epithelial cells
- (2015) Deepti R. Nagarkar et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- New and future strategies to improve asthma control in children
- (2015) William C. Anderson et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- IL-10–overexpressing B cells regulate innate and adaptive immune responses
- (2015) Barbara Stanic et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- The 3 major types of innate and adaptive cell-mediated effector immunity
- (2015) Francesco Annunziato et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Thymic stromal lymphopoietin activation of basophils in patients with allergic asthma is IL-3 dependent
- (2015) Brittany M. Salter et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Asthma phenotypes and the use of biologic medications in asthma and allergic disease: The next steps toward personalized care
- (2015) Merritt L. Fajt et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Efficacy and safety of tralokinumab in patients with severe uncontrolled asthma: a randomised, double-blind, placebo-controlled, phase 2b trial
- (2015) Christopher E Brightling et al. Lancet Respiratory Medicine
- The EAACI/GA2LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update
- (2014) T. Zuberbier et al. ALLERGY
- Real-life experiences with omalizumab for the treatment of chronic urticaria
- (2014) Gordon Sussman et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- MicroRNAs in Allergy and Asthma
- (2014) Ana Rebane et al. CURRENT ALLERGY AND ASTHMA REPORTS
- The importance of TSLP in allergic disease and its role as a potential therapeutic target
- (2014) Antonella Cianferoni et al. Expert Review of Clinical Immunology
- Mechanisms of allergen-specific immunotherapy: Multiple suppressor factors at work in immune tolerance to allergens
- (2014) Mübeccel Akdis et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Effects of an Anti-TSLP Antibody on Allergen-Induced Asthmatic Responses
- (2014) Gail M. Gauvreau et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis
- (2014) Lisa A. Beck et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma
- (2014) Elisabeth H. Bel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma
- (2014) Hector G. Ortega et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting membrane-expressed IgE B cell receptor with an antibody to the M1 prime epitope reduces IgE production
- (2014) G. M. Gauvreau et al. Science Translational Medicine
- Omalizumab for the Treatment of Inadequately Controlled Allergic Rhinitis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
- (2014) Sophia Tsabouri et al. Journal of Allergy and Clinical Immunology-In Practice
- New treatments for allergen immunotherapy
- (2014) Mübeccel Akdis World Allergy Organization Journal
- Increased efficacy of omalizumab in atopic dermatitis patients with wild-type filaggrin status and higher serum levels of phosphatidylcholines
- (2013) M. Hotze et al. ALLERGY
- Randomized, Double-Blind, Placebo-controlled Study of Brodalumab, a Human Anti–IL-17 Receptor Monoclonal Antibody, in Moderate to Severe Asthma
- (2013) William W. Busse et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Severe Refractory Atopic Dermatitis in an Adolescent Patient Successfully Treated with Ustekinumab
- (2013) Anna Agusti-Mejias et al. Annals of Dermatology
- From phenotypes to endotypes to asthma treatment
- (2013) Ioana O. Agache Current Opinion in Allergy and Clinical Immunology
- The anti-IL-17A antibody secukinumab does not attenuate ozone-induced airway neutrophilia in healthy volunteers
- (2013) A. Kirsten et al. EUROPEAN RESPIRATORY JOURNAL
- New era of biologic therapeutics in atopic dermatitis
- (2013) Emma Guttman-Yassky et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Immunologic Effects of Omalizumab in Children with Severe Refractory Atopic Dermatitis: A Randomized, Placebo-Controlled Clinical Trial
- (2013) Shuba Rajashri Iyengar et al. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
- A pilot study of omalizumab to facilitate rapid oral desensitization in high-risk peanut-allergic patients
- (2013) Lynda C. Schneider et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Dose-ranging study of lebrikizumab in asthmatic patients not receiving inhaled steroids
- (2013) Michael Noonan et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Human IL-31 is induced by IL-4 and promotes TH2-driven inflammation
- (2013) Bryony Stott et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy
- (2013) Allen Kaplan et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Dupilumab in Persistent Asthma
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- Omalizumab for the Treatment of Chronic Idiopathic or Spontaneous Urticaria
- (2013) Marcus Maurer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dupilumab in Persistent Asthma with Elevated Eosinophil Levels
- (2013) Sally Wenzel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Transient impact of omalizumab in pollen allergic patients undergoing specific immunotherapy
- (2013) Matthias Volkmar Kopp et al. PEDIATRIC ALLERGY AND IMMUNOLOGY
- A randomized, controlled trial to evaluate the effect of an anti-interleukin-9 monoclonal antibody in adults with uncontrolled asthma
- (2013) Chad K Oh et al. RESPIRATORY RESEARCH
- Untangling asthma phenotypes and endotypes
- (2012) I. Agache et al. ALLERGY
- A phase II placebo-controlled study of tralokinumab in moderate-to-severe asthma
- (2012) Edward Piper et al. EUROPEAN RESPIRATORY JOURNAL
- Immune response modifiers in the treatment of asthma: A PRACTALL document of the American Academy of Allergy, Asthma & Immunology and the European Academy of Allergy and Clinical Immunology
- (2012) Mark Ballow et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma
- (2012) Philippe Gevaert et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Omalizumab markedly improves urticaria activity scores and quality of life scores in chronic spontaneous urticaria patients: A real life survey
- (2012) Suna BÜYÜKÖZTÜRK et al. JOURNAL OF DERMATOLOGY
- Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial
- (2012) Ian D Pavord et al. LANCET
- Therapies for allergic inflammation: refining strategies to induce tolerance
- (2012) Cezmi A Akdis NATURE MEDICINE
- Asthma phenotypes: the evolution from clinical to molecular approaches
- (2012) Sally E Wenzel NATURE MEDICINE
- Mechanisms of allergen-specific immunotherapy
- (2012) Hiroyuki Fujita et al. Clinical and Translational Allergy
- Reslizumab for Poorly Controlled, Eosinophilic Asthma
- (2011) Mario Castro et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Omalizumab: Anti-IgE Therapy in Allergy
- (2011) Matthias Volkmar Kopp CURRENT ALLERGY AND ASTHMA REPORTS
- IL-33 links tissue cells, dendritic cells and Th2 cell development in a mouse model of asthma
- (2011) Thomas Eiwegger et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Interleukin-17A induces glucocorticoid insensitivity in human bronchial epithelial cells
- (2011) G. J. Zijlstra et al. EUROPEAN RESPIRATORY JOURNAL
- Treatment of severe refractory adult atopic dermatitis with ustekinumab
- (2011) Rafael Puya et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase
- (2011) Marcus Maurer et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Asthma endotypes: A new approach to classification of disease entities within the asthma syndrome
- (2011) Jan Lötvall et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Rapid oral desensitization in combination with omalizumab therapy in patients with cow’s milk allergy
- (2011) Kari C. Nadeau et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Lebrikizumab Treatment in Adults with Asthma
- (2011) Jonathan Corren et al. NEW ENGLAND JOURNAL OF MEDICINE
- Randomized Trial of Omalizumab (Anti-IgE) for Asthma in Inner-City Children
- (2011) William W. Busse et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety profile and clinical activity of multiple subcutaneous doses of MEDI-528, a humanized anti-interleukin-9 monoclonal antibody, in two randomized phase 2a studies in subjects with asthma
- (2011) Joseph M Parker et al. BMC Pulmonary Medicine
- Effects of Interleukin-13 Blockade on Allergen-induced Airway Responses in Mild Atopic Asthma
- (2010) Gail M. Gauvreau et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Efficacy and safety of etanercept in moderate-to-severe asthma: a randomised, controlled trial
- (2010) S. T. Holgate et al. EUROPEAN RESPIRATORY JOURNAL
- B-cell targeted therapies in human autoimmune diseases: an updated perspective
- (2010) Michael J. Townsend et al. IMMUNOLOGICAL REVIEWS
- Thymic stromal lymphopoietin–induced human asthmatic airway epithelial cell proliferation through an IL-13–dependent pathway
- (2010) Abdelhabib Semlali et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Anaphylaxis
- (2010) F. Estelle R. Simons JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Re-Treatment with Omalizumab at One Year Interval for Japanese Cedar Pollen-Induced Seasonal Allergic Rhinitis Is Effective and Well Tolerated
- (2009) Satoshi Ogino et al. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
- Rituximab and Omalizumab in Severe, Refractory Insulin Allergy
- (2009) Patrick F.K. Yong et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma
- (2009) Pranabashis Haldar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mepolizumab for Prednisone-Dependent Asthma with Sputum Eosinophilia
- (2009) Parameswaran Nair et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sputum Eosinophils and the Response of Exercise-Induced Bronchoconstriction to Corticosteroid in Asthma
- (2007) MyLinh Duong et al. CHEST
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started